Article thumbnail

Combined logical and data-driven models for linking signalling pathways to cellular response

By Ioannis N Melas, Alexander Mitsos, Dimitris E Messinis, Thomas S Weiss and Leonidas G Alexopoulos
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3145575
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). a Rat Model of Asthma. Am J Respir Crit Care Med
  2. (2010). A: A review of erlotinib - an oral, selective epidermal growth factor receptor tyrosine kinase inhibitor. Expert Opin Pharmaco
  3. (2009). Alexopoulos LG: Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data. PLoS Comput Biol
  4. (1999). CA: E-CELL: software environment for whole-cell simulation. Bioinformatics
  5. (2006). Califano A: ARACNE: An algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context.
  6. (2000). CR: Loss of Insulin Signalling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction. Molecular Cell
  7. (2010). CR: The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signalling. Cancer Research
  8. (2009). DA: A multipathway phosphoproteomic signalling network model of idiosyncratic drug- and inflammatory cytokine-induced toxicity Melas et al.
  9. (1999). ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science
  10. (2003). ET: Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid.
  11. (2003). Evolving concepts of rheumatoid arthritis.
  12. (2009). Fuzzy Logic Analysis of Kinase Pathway Crosstalk in TNF/EGF/InsulinInduced Signalling. Plos Computational Biology
  13. (2002). Global cancer statistics,
  14. (2005). GP: Causal ProteinSignalling Networks Derived from Multiparameter Single-Cell Data. Science
  15. (1982). Growth of Human Hepatoma Cell Lines with Differentiated Functions in Chemically Defined Medium. Cancer Research
  16. (2007). Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology
  17. (1999). Hoek JB: Quantification of short term signalling by the epidermal growth factor receptor.
  18. (2010). Inflammatory Signalling, and Hepatocellular Carcinoma An Enlarging Link. Cancer Cell
  19. (2005). Inhibiting Stat3 signalling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med
  20. (2009). Klamt S: The Logic of EGFR/ErbB Signalling: Theoretical Properties and Analysis of HighThroughput Data. Plos Computational Biology
  21. (2003). KW: Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany. Cell and Tissue Banking
  22. (2004). L: A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Cancer Research
  23. (2003). Lauffenburger D: Building with a scaffold: emerging strategies for high- to low-level cellular modeling. Trends Biotechnol
  24. (2006). Lauffenburger DA: A biological approach to computational models of proteomic networks.
  25. (2010). Logic-Based Models for the Analysis of Cell Signalling Networks. Biochemistry-Us
  26. (2003). Mass spectrometry-based proteomics. Nature
  27. (1988). Meeraus A: GAMS: User’s Guide
  28. (1999). O: A logical analysis of T cell activation and anergy.
  29. (2007). Perrimon N: Genetic screening for signal transduction in the era of network biology. Cell
  30. (2009). Personalizing medicine: a systems biology perspective. Mol Syst Biol
  31. (2000). Proteomics to study genes and genomes. Nature
  32. (2004). Regulation of the innate and adaptive immune responses by Stat-3 signalling in tumor cells. Nat Med
  33. (2009). Sawodny O: ON/OFF and Beyond - A Boolean Model of Apoptosis. PLoS Comput Biol
  34. (2006). Signal transduction of inflammatory cytokines and tumor development. Cancer Science
  35. (2005). Sorger PK: A compendium of signals and responses triggered by prodeath and prosurvival cytokines. Mol Cell Proteomics
  36. (2009). Sorger PK: Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol Syst Biol
  37. (2008). Sorger PK: Flexible informatics for linking experimental data to mathematical models via DataRail. Bioinformatics
  38. (2010). Sorger PK: Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signalling between normal and transformed hepatocytes. Mol Cell Proteomics
  39. (2006). Sorger PK: Physicochemical modelling of cell signalling pathways. Nat Cell Biol
  40. (2002). Spector NL: Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks
  41. (2010). Tang CY: Computational modeling with forward and reverse engineering links signalling network and genomic regulatory responses: NF-kappaB signalling-induced gene expression responses in inflammation.
  42. (2001). The ins and outs of signalling. Nature
  43. (2011). Training signalling pathway maps to biochemical data with constrained fuzzy logic: quantitative analysis of liver cell responses to inflammatory stimuli. PLoS Comput Biol
  44. (2007). Transforming growth factor-beta and the immune response to malignant disease. Clin Cancer Res
  45. (2000). Weinberg RA: The Hallmarks of Cancer. Cell
  46. (2005). Yaffe MB: A Systems Model of Signalling Identifies a Molecular Basis Set for Cytokine-Induced Apoptosis. Science
  47. (2006). Yaffe MB: Data-driven modelling of signal-transduction networks.
  48. (2002). Yoshimura A: Regulation of cytokine signalling and inflammation. Cytokine Growth Factor Rev
  49. (2008). Zarrinkar PP: A quantitative analysis of kinase inhibitor selectivity. Nat Biotech